Printer Friendly

DERMIK LABORATORIES ANNOUNCES JOINT VENTURE WITH INTERNATIONAL SKIN CARE COMPANY

 COLLEGEVILLE, Pa., March 18 /PRNewswire/ -- Dermik Laboratories, Inc. announced today a joint venture with RoC S.A. to market and distribute a full line of skin care products in the United States and Puerto Rico.
 The product line will feature a wide range of moisturizing, cleansing and sun protection products. RoC S.A. will manufacture all products in Paris and Dermik will act as the exclusive distributor.
 "RoC products are produced to meet the highest pharmaceutical standards of quality and purity," said Thomas Bigger, general manager and vice president of RPR Dermatologicals. "They are hypo-allergenic, perfume-free and do not cause acne."
 RoC was formed in 1957 by a pharmacist named Jean-Charles Lissarrague. Responding to requests by dermatologists, Lissarrague formulated skin care products without perfume to minimize allergic reactions. Since then, RoC has established itself as a leading manufacturer of skin care products and is the No. 1 hypo-allergenic brand in European drugstores.
 "Since Dermik is committed to dermatology, the heritage of RoC was important to us," added Bigger. "Their historical attention to the needs of the dermatologist is a perfect complement to the Dermik mission."
 RoC S.A. markets its products in more than 50 countries in the world, selling approximately 30 million units. 4.4 percent of the $120 million in annual sales is dedicated to Research and Development. Close to half of the RoC employees worldwide work directly with the medical profession.
 "There is a perfect fit between RoC and Dermik, in terms of corporate mission and the quality of our dermatological products," said Remy A. Gomez, president of RoC S.A. "This will be essential in a market like the U.S. which is of great importance for a global brand like RoC."
 Dermik Laboratories, Inc. is dedicated exclusively to dermatology. The company develops and markets both prescription and OTC pharmaceuticals for the treatment of dermatological disorders.
 /delval/
 -0- 3/18/93
 /CONTACT: Bob Pearson of Dermik Laboratories, 215-454-3872/
 (RPR)


CO: Dermik Laboratories, Inc.; RoC S.A. ST: Pennsylvania IN: MTC SU: JVN

LJ -- PH004 -- 7298 03/18/93 08:33 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 18, 1993
Words:345
Previous Article:SERVICING INDIVIDUAL SHAREHOLDERS COSTS 2X FOR BROKER-HELD STOCK, SURVEY SHOWS
Next Article:CFOs VIEW HIGHER TAXES AS GREATEST THREAT TO BUSINESS DURING THE NEXT 12 MONTHS; BUT TO REDUCE NATIONAL DEFICIT, THEY WILL TOLERATE GAS TAX
Topics:


Related Articles
SMITHKLINE BEECHAM AND DERMIK LABORATORIES SIGN CO-MARKETING AGREEMENT FOR BACTROBAN
DERMIK/RoC S.A. JOINT VENTURE INTRODUCES SKIN-CARE LINE IN U.S. MARKET
ADVANCED POLYMER SYSTEMS NAMES NEW SENIOR VICE PRESIDENT
RPR'S DERMIK DIVISION TO SET UP JOINT VENTURE IN CHINA
Noritate(TM), The First Rosacea Therapy Cleared For Both Once-Daily Dosing And Treatment Of Erythema, Is Now Available
Advanced Polymer Systems Announces Expanded Agreement With Dermik Laboratories And Initiation of Phase III Study of Microsponge(R)-Entrapped...
$1 Million Research Grant Received by the Dermatology Foundation From Dermik Laboratories, Inc.
BenzaClin(TM) Topical Gel Can Now Be Stored At Room Temperature.
VFW's Operation Uplink Receives 40,000 Phone Cards Donated by Penlac(TM) Nail Lacquer (ciclopirox) Topical Solution, 8%; Dermik Laboratories'...
First of Its Kind Online Skin, Hair and Nail Information Resource Launched; www.skinhealthsolutions.com is Linked to Nearly 300 Web Sites Containing...

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters